3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Share-based compensation

	Nine Months Ended December 31, 2014			Nine Months Ended December 31, 2013
Vesting of stock options	$	338,580		$	156,993
Incremental fair value of option modifications		–			1,914
Vesting expense associated with CEO restricted stock grant		–			64,444
Total stock-based compensation expense	$	338,580		$	223,351
Weighted average number of common shares outstanding – basic and diluted		262,722,943			187,505,561
Basic and diluted loss per common share associated with stock-based compensation expense	$	(0.00	)	$	(0.00	)

Research and development expenses

	December 31,		December 31,
	2014		2013
Three months ended	$	214,165	$	542,383
Nine months ended	$	747,657	$	1,178,488